Braden Perry, a former federal enforcement attorney who is now a regulatory and government investigations attorney with Kennyhertz Perry, discussed the Federal Trade Commission’s recent settlement of its suit related
Foreign Corrupt Practices Act and the CFTC
Most people are unaware of the fact that FedEx and UPS have been granted almost complete immunity from claims based on state law, and further, their liability for loss or
The Commodity Futures Trading Commission (“CFTC”) announced a whistleblower award totaling more than $2 million to be paid to an individual whistleblower. The CFTC granted the whistleblower’s award application for
Kennyhertz Perry attorney Arthur Chaykin presented a class on “Legal Basics for Business” at the Kauffman Foundation & Conference Center on February 21, 2019 to about 30 business owners enrolled in
For the first time, the Commodity Futures Trading Commission (CFTC) announced 2019 Examination Priorities for registrants of the Division of Market Oversight (DMO), Division of Swap Dealer & Intermediary Oversight
Kennyhertz Perry Attorney Braden Perry was recently featured in a U.S. News & World Report article discussing the pros and cons of investing in private securities. The article noted that since
Kennyhertz Perry Attorney Jeff Donoho was recently featured in Kansas City Star article on the booming business of Medical Marijuana in Missouri. The article noted that as the state publishes
The United States is a Federation, which means that our States have a certain degree of independent authority. Many states have legalized cannabis for medicinal or recreational use, but the
In its 2018 annual report, the SEC showed that during the fiscal year that ended on September 30, 2018, both the volume of the SEC’s enforcement activity and the level
Nearly two-thirds of America’s states, including Missouri, have legalized marijuana for certain uses, but the federal government still classifies marijuana as a “Schedule 1” drug, on a par with heroin.
Two recent cases in the news demonstrate the dangers of failing to consider judicious management of intellectual property rights with regard to products that include expressive content or identifiers. The
